Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug;46(2):338-353.
doi: 10.1002/jmri.25625. Epub 2017 Jan 13.

Gadolinium-based contrast agents: A comprehensive risk assessment

Tyler J Fraum  1 , Daniel R Ludwig  1 , Mustafa R Bashir  2   3 , Kathryn J Fowler  1
Affiliations
Review

Gadolinium-based contrast agents: A comprehensive risk assessment

Tyler J Fraum et al. J Magn Reson Imaging. 2017 Aug.

Abstract

Gadolinium-based contrast agents (GBCAs) have been used in magnetic resonance imaging (MRI) since the 1980s and are now administered in up to 35% of all MRI examinations. While GBCAs were initially felt to carry minimal risk, the subsequent identification of GBCAs as the key etiologic factor in the development of nephrogenic systemic fibrosis (NSF) has raised concerns about the broader health impacts of gadolinium exposure. Clinicians, radiologists, and patients should be aware of the most up-to-date data pertaining to the risks of GBCA administration. Specific issues covered in this review article include immediate adverse reactions; pregnancy and lactation; and gadolinium deposition and toxicity, with a special focus on NSF. Practice recommendations based on the presented data, as well as current professional society guidelines, are provided for each section.

Level of evidence: 1 Technical Efficacy: Stage 5 J. MAGN. RESON. IMAGING 2017;46:338-353.

Keywords: MRI; gadolinium-based contrast agent; review.

PubMed Disclaimer